NCPDP Foundation - Home

About the Foundation
The NCPDP Foundation funds research that can transform the way your healthcare providers communicate with one another and with you, leading to better and safer healthcare. Our focus is on increasing the use of standards to make the electronic exchange of healthcare information more accurate, complete and timely.
Learn More >
Research Priorities
Industry standards provide the framework for an interoperable healthcare ecosystem with better communication and coordination among everyone involved in a patient’s care. Donations to the NCPDP Foundation fund research and pilots to accelerate adoption of those standards. The priority is on projects that validate the benefits of implementing NCPDP standards that improve medication safety, timely access to needed medications, and adherence to medication therapies.
Learn More >
Recent Grants
Most recently, the Foundation awarded grants for projects that will help: prevent unnecessary dispensing of controlled substances, thereby helping to abate the opioid crisis; provide prescription benefit and patient out-of-pocket cost information at the point of care to increase speed to therapy and adherence to medications; decrease adverse events that harm patients when a prescription is discontinued, but not cancelled.
Learn More >

NCPDP Foundation Awards $115,000 Grant to Point-of-Care Partners to Help Migrate NCPDP Telecommunication Standard to JSON Format

The NCPDP Foundation Board of Trustees announced it awarded a $115,000 grant to Point-of-Care Partners to support the migration of NCPDP’s Telecommunication Standard to a JavaScript Object Notation (JSON) format, enhancing its extensibility and modernizing the real-time pharmacy claims standard. NCPDP’s Telecommunication Standard was first developed in 1988, ushering in a new and unprecedented era of real-time transactions in the pharmacy segment of healthcare. The Telecommunication Standard provides the standardized format to submit prescription drug claims, and includes transactions for eligibility verification, claim and service billing, predetermination of benefits, prior authorization, and information reporting. JSON is an open standard file format, and data interchange format, that uses human-readable text to store and transmit data objects consisting of attribute–value pairs and array data types. Read More.

NCPDP Foundation Announces a Call for Grant Proposals

The NCPDP Foundation has recently funded several research projects that have demonstrated the value of NCPDP standards in supporting patient safety and the expanded role of pharmacists, providing up-to-date information for improved clinical decision making at the point of care and improving the patient experience. Help make a difference in healthcare and submit a grant proposal for a project that aligns with the Foundation’s Vision and Purpose. To learn more about the opportunity, Read More.

Johns Hopkins Medicine Research Shows Use of NCPDP’s RTPB Standard Leads to Patient Cost Savings on Medications

A Johns Hopkins Medicine research study has proven that patients can save on their medication costs -- and sometimes acquire medications in a more timely fashion -- when physicians and pharmacy industry technology partners implement NCPDP’s Real-time Prescription Benefit (RTPB) Standard. Prescribers chose multiple types of medication changes based on point-of-care estimates provided via the RTPB Standard, saving patients an average $21.40 and as much as $1,000 at time of dispensing. Read More

NCPDP Foundation Seeking Grant Proposals for Consultant Help in Replacing the NCPDP Telecom EDI Syntax

This grant aims to support the work of the NCPDP Telecommunication Standard Modern Format Recommendation Task Group (aka TANG) in its recommended structural changes to the Telecom Standard that accelerate the ability of stakeholders to respond to the needs of the marketplace. Consultant work would include help with data modeling, design and evolving architecture. Read More

Foundation-funded Research Shows Underused ePrescribing Transaction Can Prevent Unnecessary Opioid Dispensing

An NCPDP Foundation-funded research study, conducted by the University of Wisconsin-Madison School of Pharmacy, has shown that use of NCPDP’s CancelRx transaction decreases the number of controlled substances, including opioids, that are dispensed to patients when their physicians intend those prescriptions to be discontinued. This is an important finding for the adoption of CancelRx. Read More

Johns Hopkins Medicine Study Shows CancelRx Transaction Can Protect Patients from Receiving Millions of Unintended Prescriptions

A Johns Hopkins Medicine research study, funded by the NCPDP Foundation, shows that use of NCPDP’s CancelRx ePrescribing transaction may prevent millions of prescriptions from getting into the hands of patients after their doctors’ decisions to cancel those prescriptions. Researchers found that prior to implementing CancelRx, 3.8% of prescriptions cancelled by prescribers still got into the hands of patients. This equates to more than 10 million prescriptions annually. Read More

NCPDP Foundation Awards $100,000 Grant to University of Tennessee Health Science Center to Demonstrate Value of Physician/Pharmacist Collaboration Using Pharmacist eCare Plan

The NCPDP Foundation Board of Trustees, who govern the 501(c)(3) nonprofit charitable organization that is affiliated with NCPDP, has awarded a $100,000 grant to University of Tennessee Health Science Center (UTHSC) College of Pharmacy for a research project to demonstrate the clinical value of integrating the NCPDP/HL7 Pharmacist eCare Plan (PeCP) in pharmacy and medical software systems. The Pharmacist eCare Plan is used for exchange with the patient and their care team to document medication-related health concerns and goals, as well as the pharmacist’s assessments, planned activities and interventions, recommendations, referrals, and related clinical services. Read More

Foundation Funds Video to Help Raise Awareness of How NCPDP and Pharmacists Are Filling Gaps in Patient Care

The NCPDP Foundation has just launched a new public service video that shows how NCPDP is supporting pharmacist-led COVID-19 testing…and hopefully soon, vaccine administration. The intent of the video is to raise awareness among policymakers and industry leaders of how NCPDP is working with pharmacists to help fill gaps in patient care. Foundation donors made it possible to produce this video. You can help support efforts like this by becoming a 1977 Society Donor. Read More.

NCPDP Foundation Seeking Grant Proposals For Pharmacist electronic Care Plan (PeCP) Project

The NCPDP Foundation is seeking to award a co-funded grant between $50,000-$100,000 to fund a proof of concept pilot research project to demonstrate the clinical value of the HL7/NCPDP Pharmacist eCare Plan in the HL7 FHIR format. The Pharmacist eCare Plan (PeCP) standard allows for pharmacist-level monitoring and reporting of medication adherence, health assessments, conveyance of lab results, payment opportunities and other activities related to a patient's plan of care and connects pharmacists with the patients' broader healthcare team. Read More

NCPDP Foundation Awards $100,000 to Support Real-Time Prescription Benefit (RTPB) Standard Projects at DrFirst and Johns Hopkins Medicine

The NCPDP Foundation Board of Trustees, who govern the 501(c)(3) nonprofit charitable organization that is affiliated with NCPDP, has approved $100,000 in funding to support two research projects piloting the Beta version of NCPDP’s Real-Time Prescription Benefit (RTPB) Standard.
Read More

Call for Grant Proposals for Real-time Prescription Benefit Research Project

The NCPDP Foundation is interested in awarding a grant of up to $50,000 to fund a proof of concept pilot research project on the BETA version NCPDP Real-Time Prescription Benefit (RTPB) Standard. The BETA Standard was approved by NCPDP members during the recent NCPDP Joint Technical Work Group Meetings. Grant proposals are due to the Foundation by September 30, 2019, with an announcement of the grant award to be made by November 30, 2019. Read More

NCPDP Foundation Names Former U.S. Rear Admiral Pam Schweitzer to its Board of Trustees

The NCPDP Foundation, a 501(c)(3) nonprofit charitable organization that is affiliated with NCPDP, announced today that former Assistant Surgeon General and Chief Pharmacist of the U.S. Public Health Service (PHS), Rear Admiral (RADM) Pam Schweitzer, Pharm.D., will join its NCPDP Foundation Board effectively immediately. Read More

Johns Hopkins Study Affirms Benefit of CancelRx and Leads to Enhancements

A Johns Hopkins Medicine study, funded by a $42,000 NCPDP Foundation grant, affirms the important function of the CancelRx ePrescribing transaction in decreasing adverse patient events due to medication errors, and will lead to the transaction becoming even more valuable in improving patient safety. CancelRx is an underused transaction in the NCPDP SCRIPT Standard for ePrescribing that enables prescribers to electronically cancel a prescription already submitted to a pharmacy. Read More

New Grant Helps Advance Pharmacist eCare Plan

The Foundation recently approved a $25,000 grant to the NCPA Innovation Center to help support further development of the Pharmacist eCare Plan and its adoption as a national standard. WG10 Professional Pharmacy Services initially developed the Pharmacist eCare Plan to enable pharmacists to capture their assessments of patient health status and health concerns, mutually defined patient care goals, recommendations, interventions and outcomes and to share them with other care providers, payers and the patient.

NCPDP Grant Will Demonstrate Impact of CancelRx with Controlled Substance Prescriptions

Another NCPDP Foundation grant of $36,000 to the University of Wisconsin-Madison, School of Pharmacy will demonstrate how the use of CancelRx impacts the cancellation and dispensing of controlled substance prescriptions. Use of the Cancel Rx electronic transaction can potentially minimize the number of extraneous or unnecessary controlled substance medications that are dispensed and available to patients, thereby helping to abate the opioid crisis.

Foundation Receives $1 Million Mary and Charles D. Pulido Endowment

The Foundation recently received a $1,000,000 endowment from NCPDP in honor of Mary and Charles D. Pulido. Charlie is the sole surviving co-founder of NCPDP and a founding Board member of the NCPDP Foundation. For more than 40 years, Charlie has been a passionate supporter and valued ambassador for NCPDP and now the NCPDP Foundation. Charlie and his wife, Mary, have personally donated generously to the Foundation. The endowment is a restricted fund intended to help sustain the Foundation in the long run. The principal cannot be touched -- however a percent of the interest can be used to support the Foundation’s work. The intention is for the principal to continue to grow and help ensure that the Foundation endures so its work will continue in perpetuity.